There were 2,103 press releases posted in the last 24 hours and 440,836 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Harpoon Therapeutics Presents Updated Interim Results at ASH 2022 for Novel T Cell Engager HPN217 in Relapsed/Refractory Multiple Myeloma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image